244.79
price down icon0.13%   -0.33
 
loading
전일 마감가:
$245.12
열려 있는:
$244.5
하루 거래량:
1.06M
Relative Volume:
1.02
시가총액:
$35.89B
수익:
$5.02B
순이익/손실:
$1.31B
주가수익비율:
27.47
EPS:
8.91
순현금흐름:
$1.56B
1주 성능:
+0.80%
1개월 성능:
+2.97%
6개월 성능:
-1.70%
1년 성능:
+16.93%
1일 변동 폭
Value
$242.14
$245.78
1주일 범위
Value
$242.14
$247.48
52주 변동 폭
Value
$179.42
$263.05

Resmed Inc Stock (RMD) Company Profile

Name
명칭
Resmed Inc
Name
전화
(858) 746-2400
Name
주소
9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA
Name
직원
9,980
Name
트위터
@resmed
Name
다음 수익 날짜
2024-10-24
Name
최신 SEC 제출 서류
Name
RMD's Discussions on Twitter

RMD을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Medical Instruments & Supplies icon
RMD
Resmed Inc
244.79 35.61B 5.02B 1.31B 1.56B 8.91
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
552.34 193.38B 8.71B 2.48B 1.75B 6.82
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
172.59 49.12B 20.87B 1.50B 2.59B 5.24
Medical Instruments & Supplies icon
ALC
Alcon Inc
85.94 42.79B 9.93B 1.12B 1.58B 2.25
Medical Instruments & Supplies icon
BAX
Baxter International Inc
30.50 15.46B 11.89B -560.00M 191.00M -1.10

Resmed Inc Stock (RMD) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-03-19 개시 Morgan Stanley Overweight
2025-01-16 개시 Goldman Buy
2025-01-10 개시 Piper Sandler Neutral
2024-12-13 개시 Stifel Hold
2024-09-24 개시 Robert W. Baird Outperform
2024-09-18 다운그레이드 Wolfe Research Peer Perform → Underperform
2024-09-04 다운그레이드 Needham Buy → Hold
2024-06-25 다운그레이드 Oppenheimer Outperform → Perform
2024-06-24 다운그레이드 Citigroup Buy → Neutral
2024-02-06 재개 KeyBanc Capital Markets Overweight
2023-10-27 업그레이드 Morgan Stanley Equal-Weight → Overweight
2023-10-12 다운그레이드 RBC Capital Mkts Outperform → Sector Perform
2023-10-09 업그레이드 JP Morgan Neutral → Overweight
2023-09-29 다운그레이드 Wolfe Research Outperform → Peer Perform
2023-09-06 업그레이드 Needham Hold → Buy
2023-09-05 다운그레이드 UBS Buy → Neutral
2023-08-01 업그레이드 RBC Capital Mkts Sector Perform → Outperform
2023-05-23 개시 UBS Buy
2023-04-14 개시 Mizuho Buy
2023-01-17 업그레이드 JP Morgan Neutral → Overweight
2022-10-28 다운그레이드 Citigroup Buy → Neutral
2022-10-20 업그레이드 BofA Securities Neutral → Buy
2022-10-12 개시 Jefferies Hold
2022-09-08 업그레이드 Citigroup Neutral → Buy
2022-08-15 다운그레이드 CLSA Buy → Outperform
2022-08-12 다운그레이드 Citigroup Buy → Neutral
2022-08-12 다운그레이드 JP Morgan Overweight → Neutral
2022-08-12 다운그레이드 RBC Capital Mkts Outperform → Sector Perform
2022-06-06 업그레이드 RBC Capital Mkts Sector Perform → Outperform
2022-04-06 개시 Wolfe Research Outperform
2022-01-31 업그레이드 Citigroup Neutral → Buy
2022-01-31 업그레이드 Goldman Neutral → Buy
2022-01-28 업그레이드 RBC Capital Mkts Underperform → Sector Perform
2022-01-24 업그레이드 BofA Securities Underperform → Neutral
2022-01-24 업그레이드 JP Morgan Neutral → Overweight
2022-01-13 업그레이드 CLSA Outperform → Buy
2022-01-13 업그레이드 Robert W. Baird Neutral → Outperform
2021-12-21 업그레이드 KeyBanc Capital Markets Sector Weight → Overweight
2021-12-06 업그레이드 Macquarie Neutral → Outperform
2021-10-22 업그레이드 CLSA Underperform → Outperform
2021-08-02 다운그레이드 CLSA Outperform → Sell
2021-08-02 다운그레이드 Needham Buy → Hold
2021-07-28 업그레이드 Jefferies Underperform → Hold
2021-07-26 다운그레이드 JP Morgan Overweight → Neutral
2021-07-14 개시 RBC Capital Mkts Underperform
2021-06-28 다운그레이드 Citigroup Buy → Neutral
2021-06-22 업그레이드 Macquarie Neutral → Outperform
2021-06-22 개시 Robert W. Baird Neutral
2021-06-21 재확인 Needham Buy
2021-06-16 다운그레이드 BofA Securities Neutral → Underperform
2021-06-09 업그레이드 CLSA Sell → Outperform
2021-05-21 업그레이드 JP Morgan Neutral → Overweight
2021-05-11 업그레이드 Citigroup Neutral → Buy
2021-04-30 다운그레이드 Citigroup Buy → Neutral
2021-03-16 업그레이드 Needham Hold → Buy
2020-11-02 업그레이드 UBS Neutral → Buy
2020-10-30 업그레이드 JP Morgan Underweight → Neutral
2020-10-27 업그레이드 BofA Securities Underperform → Neutral
2020-08-07 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2020-06-17 업그레이드 Morgan Stanley Equal-Weight → Overweight
2020-05-01 다운그레이드 JP Morgan Neutral → Underweight
2020-05-01 업그레이드 Oppenheimer Perform → Outperform
2020-02-18 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2020-02-03 개시 CLSA Underperform
2020-01-31 다운그레이드 UBS Buy → Neutral
2020-01-10 개시 Oppenheimer Perform
2019-11-22 개시 KeyBanc Capital Markets Sector Weight
2019-07-29 업그레이드 UBS Neutral → Buy
2019-07-16 다운그레이드 UBS Buy → Neutral
2019-05-06 업그레이드 UBS Neutral → Buy
2019-04-18 업그레이드 JP Morgan Underweight → Neutral
2019-01-25 다운그레이드 Goldman Buy → Neutral
2019-01-25 다운그레이드 JP Morgan Neutral → Underweight
2018-10-26 업그레이드 Credit Suisse Neutral → Outperform
2018-07-02 개시 Goldman Buy
모두보기

Resmed Inc 주식(RMD)의 최신 뉴스

pulisher
May 30, 2025

There's Reason For Concern Over ResMed Inc.'s (NYSE:RMD) Price - simplywall.st

May 30, 2025
pulisher
May 30, 2025

Sleep Apnea Oral Appliances MarketGlobal Forecast to 2030 with SomnoMed, Resmed, ProSomnus, DynaFlex, Vivos Therapeutics, and OpenAirway Leading - Yahoo Finance

May 30, 2025
pulisher
May 29, 2025

ResMed Inc. Files Conflict Minerals Disclosure Report for 2024 - TipRanks

May 29, 2025
pulisher
May 28, 2025

Actigraphy Devices Market Report 2025-2034 | Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscape - GlobeNewswire Inc.

May 28, 2025
pulisher
May 27, 2025

ResMed CFO Executes Stock Transaction Under Rule 10b5-1 Plan - TipRanks

May 27, 2025
pulisher
May 27, 2025

ResMed CFO Brett Sandercock sells $891,285 in stock By Investing.com - Investing.com South Africa

May 27, 2025
pulisher
May 27, 2025

Hedge Fund and Insider Trading News: Bill Ackman, Paul Tudor Jones, Chase Coleman, John Paulson, Polus Capital Management, VFC Corp (VFC), ResMed Inc (RMD), and More - Insider Monkey

May 27, 2025
pulisher
May 27, 2025

ResMed CFO Brett Sandercock sells $891,285 in stock - Investing.com Australia

May 27, 2025
pulisher
May 24, 2025

ResMed’s SWOT analysis: sleep tech giant faces growth challenges, new markets - Investing.com

May 24, 2025
pulisher
May 23, 2025

ResMed (RMD) Up 4% Since Last Earnings Report: Can It Continue? - Yahoo Finance

May 23, 2025
pulisher
May 23, 2025

Are Wall Street Analysts Bullish on ResMed Stock? - Inkl

May 23, 2025
pulisher
May 23, 2025

Are Wall Street Analysts Bullish On ResMed Stock? - Barchart.com

May 23, 2025
pulisher
May 23, 2025

Is it Worth Retaining ResMed Stock in Your Portfolio Now? - Nasdaq

May 23, 2025
pulisher
May 23, 2025

Insider Sell: Witte De Sells 2,000 Shares of ResMed Inc (RMD) - GuruFocus

May 23, 2025
pulisher
May 22, 2025

ResMed CFO Sells Shares - marketscreener.com

May 22, 2025
pulisher
May 22, 2025

Why Kogan, Monash IVF, OFX, and ResMed shares are falling today - MSN

May 22, 2025
pulisher
May 22, 2025

Down 5%: What's going on with the ResMed share price? - MSN

May 22, 2025
pulisher
May 21, 2025

RMD ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of ResMed Inc. Shareholders Who Lost Money - ACCESS Newswire

May 21, 2025
pulisher
May 21, 2025

Morgan Stanley sees ‘modest’ earnings impact to ResMed from Apnimed - Yahoo Finance

May 21, 2025
pulisher
May 21, 2025

Should you buy the dip in the ResMed share price? - MSN

May 21, 2025
pulisher
May 20, 2025

ResMed Draws Analyst Skepticism After Apnimed Announces Positive Results From Investigational Sleep Apnea Drug: Retail’s Unmoved By Stocktwits - Investing.com India

May 20, 2025
pulisher
May 20, 2025

ResMed Draws Analyst Skepticism After Apnimed Announces Positive Results From Investigational Sleep Apnea Drug: Retail’s Unmoved - MSN

May 20, 2025
pulisher
May 20, 2025

Positive Phase 3 Trial Results for RMD's Sleep Apnea Treatment | - GuruFocus

May 20, 2025
pulisher
May 20, 2025

ResMed (RMD) Faces Potential Market Challenges from New Sleep Ap - GuruFocus

May 20, 2025
pulisher
May 20, 2025

ResMed (RMD) Faces Potential Market Challenges from New Sleep Apnea Treatment | RMD Stock News - GuruFocus

May 20, 2025
pulisher
May 19, 2025

Here's Why ResMed (RMD) is a Strong Growth Stock - Yahoo Finance

May 19, 2025
pulisher
May 18, 2025

ResMed (NYSE:RMD) Seems To Use Debt Rather Sparingly - simplywall.st

May 18, 2025
pulisher
May 15, 2025

Apnea Therapy Market Is Booming Worldwide 2025-2032 | ResMed Inc., Koninklijke Philips N.V. - openPR.com

May 15, 2025
pulisher
May 15, 2025

Resmed (RMD) Partners with Rugby Tour to Promote Sleep Health | - GuruFocus

May 15, 2025
pulisher
May 15, 2025

ResMed named Sleep Partner of the Qatar Airways British & Irish Lions Tour - TipRanks

May 15, 2025
pulisher
May 15, 2025

Resmed Champions Sleep Health as The Official Sleep Partner of The Qatar Airways British & Irish Lions Tour to Australia 2025 - The Spec

May 15, 2025
pulisher
May 15, 2025

Patient Monitoring Stocks Q1 Teardown: ResMed (NYSE:RMD) Vs The Rest - Yahoo Finance

May 15, 2025
pulisher
May 11, 2025

Resmed Inc Updates Dividend Exchange Rate for CDI Holders - TipRanks

May 11, 2025
pulisher
May 09, 2025

Levi & Korsinsky Reminds ResMed Investors of the Ongoing Investigation into Potential Violations of Securities LawsRMD - ACCESS Newswire

May 09, 2025
pulisher
May 09, 2025

ResMed CEO Michael Farrell sells $1.95m in stock By Investing.com - Investing.com Canada

May 09, 2025
pulisher
May 09, 2025

Resmed Insider Sold Shares Worth $1,948,003, According to a Recent SEC Filing - marketscreener.com

May 09, 2025
pulisher
May 09, 2025

ResMed CEO Michael Farrell sells $1.95m in stock - Investing.com

May 09, 2025
pulisher
May 08, 2025

Insider Sell: Peter Farrell Sells 2,000 Shares of ResMed Inc (RMD) - GuruFocus

May 08, 2025
pulisher
May 07, 2025

Resmed prevails over Cleveland Medical in CPAP patent review - BioWorld MedTech

May 07, 2025
pulisher
May 06, 2025

Is ResMed Inc.'s (NYSE:RMD) Latest Stock Performance A Reflection Of Its Financial Health? - simplywall.st

May 06, 2025
pulisher
May 06, 2025

Ex-Dividend Reminder: Seaboard, KB Home and ResMed - Nasdaq

May 06, 2025
pulisher
May 05, 2025

ResMed Inc Reports Changes in CDIs and Securities for April 2025 - TipRanks

May 05, 2025
pulisher
May 05, 2025

Jim Cramer on Viemed Healthcare (VMD): “Interesting, But I’m a ResMed Guy” - Yahoo Finance

May 05, 2025
pulisher
May 05, 2025

ResMed Wins Invalidation of Sleep Apnea Tech Patent After Remand - Bloomberg Law News

May 05, 2025
pulisher
May 03, 2025

Is It Smart To Buy ResMed Inc. (NYSE:RMD) Before It Goes Ex-Dividend? - Yahoo Finance

May 03, 2025
pulisher
May 02, 2025

ResMed Corporation: GLP-1 Demand Generation Strategy to Expand Customer Base & Strengthen Their Position! - Smartkarma

May 02, 2025
pulisher
May 02, 2025

Intuitive wins new FDA nod for single port robot; Resmed buys diagnostic facility - MedTech Dive

May 02, 2025

Resmed Inc (RMD) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
medical_instruments_supplies ALC
$85.94
price down icon 0.47%
medical_instruments_supplies BDX
$172.59
price down icon 0.71%
medical_instruments_supplies BAX
$30.50
price down icon 0.65%
medical_instruments_supplies WST
$210.85
price up icon 0.19%
$62.17
price down icon 1.19%
자본화:     |  볼륨(24시간):